LncRNA XIST、miR-204及FN1在甲状腺乳头状癌中的表达及意义
Expression and Significance of LncRNA XIST, miR-204 and FN1 in Papillary Thyroid Carcinoma
DOI: 10.12677/ACM.2021.117441, PDF,    科研立项经费支持
作者: 孙茂林, 张文伟, 姜立伟, 臧传善, 秦作荣, 王效军, 孙 彦, 邱 杰*:青岛大学附属医院,山东 青岛;刘明波*:中国人民解放军总医院海南医院,海南 三亚
关键词: LncRNA XIST基因miR-204基因FN1基因甲状腺乳头状癌LncRNA XIST Gene miR-204 Gene FN1 Gene PTC
摘要: 目的:探讨LncRNA XIST,miR-204及FN1在PTC组织和癌旁组织及LncRNA XIST在PTC细胞系中的表达及意义。方法:应用Real-time PCR技术检测20例甲状腺乳头状癌和其癌旁组织中LncRNA XIST,miR-204及FN1的表达情况,应用QPCR检测3株甲状腺癌细胞系(BCPAP, TPC-1, KTC-1) LncRNA XIST、miR-204-5p的表达水平,应用荧光原位杂交(FISH)检测PTC细胞系BCPAP中LncRNA XIST的表达定位,应用双荧光素酶报告基因检测人293T细胞的LncRNA XIST、miR-204及FN1相互作用。结果:与癌旁组相比,PTC癌组织组的LncRNA XIST的表达水平显著上调(p < 0.05),PTC癌组织组的FN1的表达水平极显著上调(p < 0.01),而PTC癌组织组的miR-204-5p的表达水平极显著下调(p < 0.01),差异均具有统计学意义;BCPAP细胞的LncRNA XIST的表达水平最高,且miR-204-5p的表达水平最低;LncRNA XIST主要在细胞质中表达;LncRNA XIST与miR-204有相互作用(p < 0.05),FN1与miR-204有相互作用(p < 0.05)。结论:LncRNA XIST在甲状腺乳头状癌中高表达,miR-204在甲状腺乳头状癌中低表达,FN1在甲状腺乳头状癌中高表达;LncRNA XIST,miR-204及FN1相互作用,参与甲状腺乳头状癌的发生发展,并可为甲状腺乳头状癌潜在诊断标志物和治疗靶点的寻找提供理论依据,LncRNA XIST可能是甲状腺乳头状癌诊断和治疗的一个新靶点。
Abstract: Objective: To investigate the expression and significance of LncRNA XIST, miR-204 and FN1 in PTC tissues and adjacent tissues, and LncRNA XIST in PTC cell lines. Method: The expression of LncRNA XIST, miR-204 and FN1 in 20 cases of papillary thyroid carcinoma and its adjacent tissues were detected by Real-time PCR technology, and 3 thyroid cancer cell lines (BCPAP, TPC-1, KTC-1) were detected by QPCR, the expression levels of LncRNA XIST and miR-204-5p were detected by fluorescence in situ hybridization (FISH) to detect the expression and location of LncRNA XIST in the PTC cell line BCPAP, and double luciferase reporter gene was used to detect the interaction of LncRNA XIST, miR-204 and FN1 in human 293T cells. Result: The expression level of LncRNA XIST in the PTC cancer tissue group was significantly increased in comparison with the adjacent group (p < 0.05), the expression level of FN1 in the PTC cancer tissue group was extremely significantly up-regulated (p < 0.01), while the expression level of miR-204-5p in the PTC cancer tissue group was extremely significantly down-regulated (p < 0.01), the differences are statistically significant;the expression level of LncRNA XIST in BCPAP cells was the highest, and the expression level of miR-204-5p was the lowest; LncRNA XIST was mainly expressed in the cytoplasm; LncRNA XIST interacted with miR-204 (p < 0.05), and FN1 interacted with miR-204 (p < 0.05). Conclusion: LncRNA XIST is highly expressed in papillary thyroid carcinoma, miR-204 is low expressed in papillary thyroid carcinoma, and FN1 is highly expressed in papillary thyroid carcinoma; the interaction between LncRNA XIST, miR-204 and FN1 is involved in the occurrence and development of thyroid papillary carcinoma, and can provide a theoretical basis for the search of potential diagnostic markers and therapeutic targets for thyroid papillary carcinoma. LncRNA XIST may be a new target for the diagnosis and treatment of thyroid papillary carcinoma.
文章引用:孙茂林, 张文伟, 姜立伟, 臧传善, 秦作荣, 王效军, 孙彦, 刘明波, 邱杰. LncRNA XIST、miR-204及FN1在甲状腺乳头状癌中的表达及意义[J]. 临床医学进展, 2021, 11(7): 3033-3046. https://doi.org/10.12677/ACM.2021.117441

参考文献

[1] Siraj, A.K., Hussain, A.R., Alrasheed, M., et al. (2011) Demethylation of TMS1 Gene Sensitizes Thyroid Cancer Cells to TRAIL-Induced Apoptosis. The Journal of Clinical Endocrinology and Metabolism, 96, E215-E224. [Google Scholar] [CrossRef] [PubMed]
[2] Kim, H.I., et al. (2018) Refining the Eighth Edition AJCC TNM Classification and Prognostic Groups for Papillary Thyroid Cancer with Lateral Nodal Metastasis. Oral Oncology, 78, 80-86. [Google Scholar] [CrossRef] [PubMed]
[3] Shteinshnaider, M., et al. (2018) Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study. Thyroid, 28, 201-209. [Google Scholar] [CrossRef] [PubMed]
[4] Londero, S.C., et al. (2013) Papillary Thyroid Microcarcinoma in Denmark 1996-2008: A National Study of Epidemiology and Clinical Significance. Thyroid, 23, 1159-1164. [Google Scholar] [CrossRef] [PubMed]
[5] Gong, Y., et al. (2018) MiR-26a Inhibits Thyroid Cancer Cell Proliferation by Targeting ARPP19. American Journal of Cancer Research, 8, 1030-1039.
[6] Vaisman, F., Corbo, R. and Vaisman, M. (2011) Thyroid Carcinoma in Children and Adolescents-Systematic Review of the Literature. Journal of Thyroid Research, 2011, Article ID: 845362. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, X., et al. (2018) A Potential Biomarker hsa-miR-200a-5p Distinguishing between Benign Thyroid Tumors with Papillary Hyperplasia and Papillary Thyroid Carcinoma. PLoS ONE, 13, e0200290. [Google Scholar] [CrossRef] [PubMed]
[8] Kim, S.K., Lee, J.H., Woo, J.W., et al. (2015) Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation. Medicine, 94, e760. [Google Scholar] [CrossRef
[9] Arjumand, W., Asiaf, A. and Ahmad, S.T. (2018) Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics. Methods in Molecular Biology, 1699, 3-21. [Google Scholar] [CrossRef] [PubMed]
[10] 佘春晖. LncRNA XIST在原发性胆汁性胆管炎免疫细胞中的作用研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2020.
[11] Spizzo, R., et al. (2012) Long Non-Coding RNAs and Cancer: A New Frontier of Translational Research. Oncogene, 31, 4577-4587. [Google Scholar] [CrossRef] [PubMed]
[12] 李墨林, 贾婷婷, 白晗, 李传刚, 李连宏. MicroRNA与甲状腺癌发生、发展关系的研究进展[J]. 临床与实验病理学杂志, 2015, 31(7): 794-798.
[13] Plath, K., et al. (2002) Xist RNA and the Mechanism of X Chromosome Inactivation. Annual Review of Genetics, 36, 233-278. [Google Scholar] [CrossRef] [PubMed]
[14] Engreitz, J.M., et al. (2013) The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread across the X Chromosome. Science, 341, Article ID: 1237973. [Google Scholar] [CrossRef] [PubMed]
[15] McHugh, C.A., et al. (2015) The Xist lncRNA Interacts Directly with SHARP to Silence Transcription through HDAC3. Nature, 521, 232-236. [Google Scholar] [CrossRef] [PubMed]
[16] Ma, L., Deng, X., Wu, M., et al. (2014) Down-Regulation of miRNA-204 by LMP-1 Enhances CDC42 Activity and Facilitates Invasion of EBV-Associated Nasopharyngeal Carcinoma Cells. FEBS Letters, 588, 1562-1570. [Google Scholar] [CrossRef] [PubMed]
[17] Vimalraj, S., Miranda, P.J., Ramyakrishna, B., et al. (2013) Regulation of Breast Cancer and Bone Metastasis by MicroRNAs. Disease Markers, 35, 369-387. [Google Scholar] [CrossRef] [PubMed]
[18] Ryan, J., Tivnan, A., Fay, J., et al. (2012) microRNA-204 Increases Sensitivity of Neuroblastoma Cells to Cisplatin and Is Associated with a Favourable Clinical Outcome. British Journal of Cancer, 107, 967-976. [Google Scholar] [CrossRef] [PubMed]
[19] Zeng, L., Yu, J., Huang, T., et al. (2012) Differential Combinatorial Regulatory Network Analysis Related to Venous Metastasis of Hepatocellular Carcinoma. BMC Genomics, 13, S14. [Google Scholar] [CrossRef
[20] Polyak, K. and Weinberg, R.A. (2009) Transitions between Epithelial and Mesenchymal States: Acquisition of Malignant and Stem Cell Traits. Nature Reviews Cancer, 9, 265-273. [Google Scholar] [CrossRef] [PubMed]
[21] Sampayo, R.G., et al. (2018) Fibronectin Rescues Estrogen Receptor Alpha from Lysosomal Degradation in Breast Cancer Cells. Journal of Cell Biology, 217, 2777-2798. [Google Scholar] [CrossRef] [PubMed]
[22] Ruiz-Garcia, E., et al. (2010) Gene Expression Profiling Identifies Fibronectin 1 and CXCL9 as Candidate Biomarkers for Breast Cancer Screening. British Journal of Cancer, 102, 462-468. [Google Scholar] [CrossRef] [PubMed]
[23] Jerhammar, F., et al. (2010) Fibronectin 1 Is a Potential Biomarker for Radioresistance in Head and Neck Squamous Cell Carcinoma. Cancer Biology & Therapy, 10, 1244-1251. [Google Scholar] [CrossRef] [PubMed]
[24] Karpinsky, G., et al. (2018) Tumor Expression of Survivin, p53, Cyclin D1, Osteopontin and Fibronectin in Predicting the Response to Neo-Adjuvant Chemotherapy in Children with Advanced Malignant Peripheral Nerve Sheath Tumor. Journal of Cancer Research and Clinical Oncology, 144, 519-529. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, J., et al. (2017) High Expression of Fibronectin 1 Suppresses Apoptosis through the NF-kappaB Pathway and Is Associated with Migration in Nasopharyngeal Carcinoma. American Journal of Translational Research, 9, 4502-4511.
[26] Sun, K., Jia, Z., Duan, R., et al. (2019) Long Non-Coding RNA XIST Regulates miR-106b-5p/P21 Axis to Suppress Tumor Progression in Renal Cell Carcinoma. Biochemical and Biophysical Research Communications, 510, 416-420. [Google Scholar] [CrossRef] [PubMed]
[27] 邢益桓, 付斌, 夏鹰. lncRNA XIST介导的ceRNA调控网络在恶性肿瘤中作用的研究进展[J]. 中国肿瘤生物治疗杂志, 2020, 27(9): 1062-1067.
[28] Wapinski, O. and Chang, H.Y. (2011) Long Noncoding RNAs and Human Disease. Trends in Cell Biology, 21, 354-361. [Google Scholar] [CrossRef] [PubMed]
[29] Ab Mutalib, N.S., et al. (2016) Integrated microRNA, Gene Expression and Transcription Factors Signature in Papillary Thyroid Cancer with Lymph Node Metastasis. PeerJ, 4, e2119. [Google Scholar] [CrossRef] [PubMed]
[30] 涂超峰, 武明花, 李桂源. lncRNA与miRNA相互调控作用及其与肿瘤的关系[J]. 中国生物化学与分子生物学报, 2013, 29(11): 1029-1034.
[31] Wang, J.Y., Liu, X.F., Wu, H.C., Ni, P.H., Gu, Z.D., Qiao, Y.X., Chen, N., Sun, F.Y. and Fan, Q.S. (2010) CREB Up-Regulates Long Non-Coding RNA, HULC Expression through Interaction with microRNA-372 in Liver Cancer. Nucleic Acids Research, 38, 5366-5383. [Google Scholar] [CrossRef] [PubMed]
[32] 王帅, 李文雅. lncRNA XIST调控miR-486-5p影响食管癌细胞增殖的实验研究[J]. 现代肿瘤医学, 2020(4): 539-543.
[33] 刘颖. 过表达lncRNA GAS5对甲状腺乳头状癌侵袭和迁移能力的影响及机制研究[J]. 标记免疫分析与临床, 2020, 27(10): 1761-1766+1776.
[34] 杨梅柳. LncRNA在甲状腺乳头状癌中的表达及功能分析[D]: [博士学位论文]. 石家庄: 河北医科大学, 2016.
[35] 王科, 王应强, 叶静, 张雪, 钟玲, 杨力, 马世丽. LncRNA RP11-316M1.12在甲状腺乳头状癌中的表达及对细胞侵袭、迁移的影响[J]. 现代生物医学进展, 2020(14): 2646-2650+2622.
[36] 林冲, 王霄. 基于竞争性内源RNA的甲状腺乳头状癌淋巴结转移差异性lnRNA-miRNA-mRNA差异网络的构建与分析[J]. 饮食保健, 2020, 7(22): 48-49.
[37] 何亚丽, 毛玉娟, 杨锐, 江华, 谢青, 申进增, 伊琳, 顾远辉. lncRNA在甲状腺乳头状癌中的研究进展[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(68): 65-68.